Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Others	6.58B	6.51B	7.06B	6.84B	6.76B
Unallocated Adjustment	-12.17B	-11.68B	-14.28B	-14.82B	-13.60B
International Business	48.42B	46.84B	44.13B	41.55B	31.14B
Domestic Business (Incl. Mail Order Business)	122.92B	123.92B	136.54B	-	-
Domestic Business	-	-	-	124.24B	121.96B
Mail Order Business	-	-	-	8.44B	8.99B
Total	165.74B	165.60B	173.46B	166.26B	155.25B

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Japan	118.75B	120.42B	131.16B	126.58B	125.51B
USA	23.81B	21.25B	17.06B	16.47B	13.01B
China	9.61B	-	13.65B	12.48B	10.07B
Southeast Asia	9.30B	-	7.93B	7.49B	4.21B
Others	4.27B	23.93B	3.65B	3.23B	2.46B
Total	165.74B	165.60B	173.45B	166.26B	155.25B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error